About Aburaihan Pharmaceuticals Co
Founded as Berlimed of Iran under German Schering’s ownership, the company was renamed Aburaihan Pharmaceuticals in 1981. It became a public joint-stock company in 1991, maintaining a steadfast commitment to producing high-quality pharmaceuticals that meet international standards.
With a mission to improve health and hygiene worldwide, Aburaihan Pharmaceuticals leverages modern technology, research, and expertise to develop effective solutions for both human and veterinary healthcare.
Product Portfolio
Aburaihan Pharmaceuticals offers a diverse range of pharmaceutical products, focusing on:
1. Human Medicines
- Hormonal Products: Including treatments for endocrinology and metabolism.
- Cardiovascular and Neurology: Addressing key health challenges.
- Respiratory Care: Providing solutions for chronic and acute conditions.
2. Veterinary Medicines
Since 1991, the company has been a significant player in the veterinary sector, manufacturing medicines that ensure animal health and productivity.
Quality Standards and Certifications
Aburaihan Pharmaceuticals is dedicated to upholding the highest quality standards, including:
- International Certifications: Compliance with ISO 9001:2000, ISO 14001:2004, and OHSAS 18001:2007.
- Regulatory Standards: Adherence to GXP, PICS, and WHO guidelines, ensuring product safety and efficacy.
- Pharmacopeial Standards: Meeting USP, BP, and EP requirements for all formulations.
These stringent quality measures reflect the company’s commitment to delivering trusted healthcare solutions.
Global Presence and Export Markets
Aburaihan Pharmaceuticals has established a robust international presence, exporting its products to over 15 countries, including:
- Middle East: Iraq, Syria, Lebanon.
- Asia: Afghanistan, Vietnam, Thailand.
- Europe: Azerbaijan, Georgia, Ukraine.
- Africa: Uganda and beyond.
The company’s growing export footprint underscores its dedication to global health.
Research and Development
Innovation lies at the heart of Aburaihan Pharmaceuticals. The company invests heavily in research and development to create advanced medications that address emerging healthcare needs. Their R&D team focuses on improving existing products and developing new formulations to meet international standards.
Corporate Social Responsibility (CSR)
As a socially responsible organization, Aburaihan Pharmaceuticals is deeply committed to:
- Promoting public health and hygiene.
- Implementing environmentally sustainable practices.
- Supporting local communities through various health initiatives.
Recent Achievements and Developments
Aburaihan Pharmaceuticals continues to make strides in the pharmaceutical industry with:
- New Product Launches: Expanding its portfolio of innovative medicines.
- Strategic Partnerships: Collaborating with international organizations to enhance healthcare delivery.
- Global Recognition: Gaining accolades for quality and innovation.
Why Choose Aburaihan Pharmaceuticals?
- Trusted Quality: All products are rigorously tested to meet global standards.
- Wide Range of Solutions: Comprehensive offerings for both human and veterinary health.
- Global Reach: A strong presence in international markets.
- Commitment to Innovation: Continuous R&D ensures the development of cutting-edge treatments.
- Sustainability: Dedicated to creating a healthier world through ethical and environmentally conscious practices.
Conclusion
With of excellence, Aburaihan Pharmaceuticals Co stands out as a trusted leader in the global pharmaceutical industry. Their dedication to innovation, quality, and sustainability ensures they continue to make a meaningful impact on health and well-being worldwide.